Regulation of IFN-beta induction by P2X7 purinergic receptor signaling
P2X7 嘌呤能受体信号传导对 IFN-β 诱导的调节
基本信息
- 批准号:7936194
- 负责人:
- 金额:$ 13.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-25 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adenine NucleotidesAgonistAntiviral AgentsAreaAutoimmune DiseasesAutoimmune ProcessBasic ScienceBindingBiologyBlood PlateletsCD14 AntigenCalciumCalcium SignalingCationsCellsCessation of lifeClinicalCollaborationsComplexContinuing EducationCytolysisCytoplasmic TailDataDendritic cell activationDevelopment PlansDevelopmental ProcessDiseaseDouble-Stranded RNAEmployee StrikesEndotoxinsEnvironmentEquipmentFacultyFamilyFundingG-Protein-Coupled ReceptorsGenesGenetic TranscriptionGoalsImmuneImmune responseInfectionInflammationInflammatoryInterferon-betaInterferonsLeadLigandsLigationLipopolysaccharidesMAP Kinase Activation PathwayMAP Kinase Signaling PathwaysMAPK14 geneMAPK8 geneMediatingMedicalMembraneMentorsMessenger RNAMitogen-Activated Protein KinasesModificationMorphogenesisMusNatural ImmunityNitric OxideNucleotidesOsteitisOsteoporosisP2X-receptorPathway interactionsPhysiciansPlayPrincipal InvestigatorProcessProductionPurine NucleotidesPurinesPurinoceptorReceptor SignalingRegulationResearchResearch Project GrantsRoleSchoolsScientistSepsisSignal InductionSignal TransductionSignal Transduction PathwaySiteStimulusStudy SectionTLR4 geneTechniquesTestingTimeTissuesTrainingUniversitiesVirus DiseasesWisconsinWorkadaptive immunityanalogbactericidebonecareercareer developmentchromatin immunoprecipitationcytokineextracellularimmunoregulationimprovedinterestmacrophagemembernovelnucleotide analognucleotide receptorpediatric departmentprogramspromoterpurinereceptorrelease of sequestered calcium ion into cytoplasmresponsesmall moleculetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Goals: My long-term research goal is to gain a greater understanding of the regulation of type I IFN production by macrophages, cells that are key players in inflammation. As a physician-scientist, it is my hope that these studies will eventually contribute to the improved treatment of inflammatory and autoimmune conditions. My immediate career goal is to develop a viable independent research program. Research project: During inflammation, the occurrence of tissue damage leads to sufficient release of extracellular purine nucleotides to stimulate immune cells via purinergic receptors such as P2X7. Stimulation of P2X7 by ATP is well known to increase the production of inflammatory cytokines (e.g. IL-1¿) by macrophages stimulated with endotoxin (LPS). We have found that co-stimulation of macrophages with LPS and the ATP analogue BzATP greatly augments the induction of IFN- ¿ by LPS. Type I IFNs play important roles in diverse aspects of innate and adaptive immunity. As both IFN- ¿ and purinergic receptor signaling have been implicated in bacterial sepsis and bone morphogenesis, it is critical to understand the mechanism of how P2X7 modulates the induction of IFN- ¿. To begin dissecting the mechanism of how P2X7 exerts its effect, a multi-pronged approach is proposed: We will examine the effect of P2X7 ligation on IFN- ¿ induction by different infectious stimuli (e.g. LPS, dsRNA etc.) to determine whether P2X7 enhancement is LPS specific. P2X7 ligation is known to initiate multiple signal transduction pathways: the contribution of calcium and MAP-kinase signaling pathways to the effect of BzATP on IFN- ¿ induction will be analyzed. Finally, we will examine the recruitment of transcription factors to the IFN- ¿ gene promoter by chromatin immunoprecipitation to test our underlying hypothesis that P2X7 ligation leads to increased transcription factor occupancy of the ifnb1 promoter. Modification of transcription factor recruitment by P2X7 mediated signaling has ramifications for the enhancement of immune responses and bone biology. Career development plan: The two key components are close collaboration with Paul Bertics and more formal oversight by a mentoring committee. Paul Bertics has abundant expertise in my area of interest and an excellent track record in training junior faculty. In addition to Dr. Bertics, my committee is composed of three other very supportive and successful physician scientists. Research environment: Through the department of Pediatrics, I have been accorded lab space, protected time and initial start-up funds. The breadth of expertise present at the University of Wisconsin, through the Medical and Graduate schools, is tremendous. Any equipment or technical assistance I should require will be available. There are ample forums for intellectual exchange as well as continuing education in the clinical and basic sciences.
RELEVANCE: Macrophages participate in many inflammatory processes including responses to infections and autoimmune diseases by secreting cytokines. My research proposes to study how substances that are released by tissue damage called "purines" regulate the production of the inflammatory cytokine IFN- ¿ by macrophages. Greater understanding of inflammatory processes may ultimately lead to the better treatment of disease.
描述(由申请人提供): 目标:我的长期研究目标是更好地了解巨噬细胞(炎症中的关键细胞)对 I 型干扰素产生的调节,作为一名医生科学家,这是我的希望。这些研究最终将有助于改善炎症和自身免疫性疾病的治疗,我的近期职业目标是开发一个可行的独立研究项目:在炎症过程中,组织损伤的发生导致细胞外嘌呤核苷酸的充分释放。众所周知,ATP 刺激 P2X7 会增加内毒素 (LPS) 刺激的巨噬细胞产生炎症细胞因子(例如 IL-1¿)。与 LPS 和 ATP 类似物 BzATP 一起大大增强 IFN-¿ I 型干扰素在先天性和适应性免疫的各个方面发挥着重要作用。由于嘌呤能受体信号传导与细菌性脓毒症和骨形态发生有关,因此了解 P2X7 如何调节 IFN-¿ 诱导的机制至关重要。为了开始剖析 P2X7 如何发挥其作用的机制,提出了一种多管齐下的方法:我们将检查 P2X7 连接对 IFN-¿通过不同的感染刺激(例如 LPS、dsRNA 等)进行诱导以确定 P2X7 增强是否是 LPS 特异性的,已知 P2X7 连接会启动多种信号转导途径:钙和 MAP 激酶信号途径对 BzATP 对 IFN 的影响的贡献。 - ¿最后,我们将检查转录因子对 IFN-¿ 的招募。通过染色质免疫沉淀法检测基因启动子,以测试我们的基本假设,即 P2X7 连接导致 ifnb1 启动子的转录因子占据增加。 P2X7 介导的信号传导对转录因子募集的修饰对增强免疫反应和骨生物学具有影响。两个关键组成部分是与 Paul Bertics 的密切合作以及指导委员会更正式的监督 Paul Bertics 在我感兴趣的领域拥有丰富的专业知识,并且在培训初级教师方面拥有出色的记录。除了 Bertics 博士之外,我的委员会还由其他三位非常支持和成功的医师科学家组成: 通过儿科,我获得了实验室空间、受保护的时间和初始启动资金 广泛的专业知识。威斯康星大学通过医学院和研究生院提供了大量的知识交流以及临床和基础科学继续教育的论坛。
相关性:巨噬细胞通过分泌细胞因子参与许多炎症过程,包括对感染和自身免疫性疾病的反应。我的研究建议研究组织损伤释放的称为“嘌呤”的物质如何调节炎症细胞因子 IFN-¿ 的产生。对炎症过程的更多了解可能最终导致更好的疾病治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Judith Anne Smith其他文献
Judith Anne Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Judith Anne Smith', 18)}}的其他基金
Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data
使用真实世界临床数据识别预测 COVID-19 相关儿童多系统炎症综合征 (MISC) 结果的风险因素
- 批准号:
10527735 - 财政年份:2022
- 资助金额:
$ 13.99万 - 项目类别:
Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data
使用真实世界临床数据识别预测 COVID-19 相关儿童多系统炎症综合征 (MISC) 结果的风险因素
- 批准号:
10679093 - 财政年份:2022
- 资助金额:
$ 13.99万 - 项目类别:
Regulation of human immune function by 17q21 asthma risk polymorphism
17q21哮喘风险多态性对人体免疫功能的调节
- 批准号:
9334706 - 财政年份:2016
- 资助金额:
$ 13.99万 - 项目类别:
Regulation of IFN-beta induction by P2X7 purinergic receptor signaling
P2X7 嘌呤能受体信号传导对 IFN-β 诱导的调节
- 批准号:
8129777 - 财政年份:2009
- 资助金额:
$ 13.99万 - 项目类别:
Regulation of IFN-beta induction by P2X7 purinergic receptor signaling
P2X7 嘌呤能受体信号传导对 IFN-β 诱导的调节
- 批准号:
7571208 - 财政年份:2009
- 资助金额:
$ 13.99万 - 项目类别:
相似国自然基金
内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
- 批准号:32300565
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水体中β2-肾上腺素受体激动剂(PPCPs)间接光降解机理的量子化学与实验研究
- 批准号:22306084
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV4/SKCa信号轴在AMPK激动剂抑制微小动脉舒张作用中的机制研究
- 批准号:82304584
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于纳米铝乳剂和模式识别受体激动剂的复合型佐剂研究
- 批准号:82341043
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
相似海外基金
Antiviral innate immune responses to pathogenic coronaviruses in the nasal epithelium
鼻上皮中针对致病性冠状病毒的抗病毒先天免疫反应
- 批准号:
10678393 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Development of a RIG-I agonist RNA as a cure for chronic Hepatitis B
开发 RIG-I 激动剂 RNA 来治疗慢性乙型肝炎
- 批准号:
10699796 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Development of a RIG-I agonist RNA as a cure for chronic Hepatitis B
开发 RIG-I 激动剂 RNA 来治疗慢性乙型肝炎
- 批准号:
10699796 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
米托醌/甲磺酸米托喹诺作为 Covid-19 的口服且安全的暴露后预防
- 批准号:
10727092 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别:
Novel regulatory mechanisms and agonists of STING
STING 的新颖调控机制和激动剂
- 批准号:
10655761 - 财政年份:2023
- 资助金额:
$ 13.99万 - 项目类别: